> Spin-offs 2010
The Spin-off Panel enables potential investors, partners or licensees to learn about additional, comparatively advanced projects and encourages entrepreneurs to present their businesses in a way that appeals to experienced decision makers from the biopharmaceutical industry. It will combine a challenging question time with one-slide and poster presentations.
Alex Martin, Dr Luc St-Onge, Dr Michael Bös
Dr Thomas Schmid
Dr Carsten Rudolph, Dr Christian Plank
Xavier Regnaut
Christian Wiest
Dr Bert Klebl, Dr Peter Nussbaumer
Dr Stefan Muellner, Martin Blueggel, Dr Peter Schulz-Knappe
Prof. Uwe Jacob, Prof. Georg Fey
Prof. Peter Buckel, Dr Robert Phelps